Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells.
about
The placental RCAS1 expression during stillbirthThe analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration.Therapeutic angiogenesis by ex vivo expanded erythroid progenitor cells.The evaluation of metallothionein expression in nasal polyps with respect to immune cell presence and activity.Tumor-associated, estrogen receptor-related antigen EBAG9: linking intracellular vesicle trafficking, immune homeostasis, and malignancy.The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens.The Involvement of RCAS1 in Creating a Suppressive Tumor Microenvironment in Patients with Salivary Gland AdenocarcinomaComparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomasNovel serum tumor marker, RCAS1, in pancreatic diseasesExpression of RCAS1 correlates with urothelial bladder cancer malignancyThe analysis of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) immunoreactivity within the microenvironment of the ovarian cancer lesion relative to the applied therapeutic strategy.The erythroblastic islandMaking Blood: The Haematopoietic Niche throughout Ontogeny.Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Targeted gene deletion demonstrates that the cell adhesion molecule ICAM-4 is critical for erythroblastic island formationAnalysis of the intensity of immune cell infiltration and immunoreactivity of RCAS1 in diffuse large B-cell lymphoma of the palatine tonsil and its microenvironment.RCAS1 expression in mobile tongue squamous cell carcinoma: an immunohistochemical studyReceptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in human benign and malignant thyroid lesionsErythroblastic islands: niches for erythropoiesis.Increased RCAS1 expression is associated with advanced histopathological stage and poor prognosis in patients with gastric adenocarcinomaThe tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells.Novel hydrophilic docetaxel (CQMU-0519) analogue inhibits proliferation and induces apoptosis in human A549 lung, SKVO3 ovarian and MCF7 breast carcinoma cell lines.The Effect of Baicalin as A PPAR Activator on Erythroid Differentiation of CD133(+)Hematopoietic Stem Cells in Umbilical Cord BloodEBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma.A novel mechanism in suppression of erythropoiesis during inflammation: a crucial role of RCAS1.Antitumor immunity and cancer stem cellsRole of NF-kappa B in regulation of apoptosis of erythroid progenitor cells.Pivotal role of Notch signaling in regulation of erythroid maturation and proliferation.Expression of tumor-associated antigen RCAS1 and its possible involvement in immune evasion in oral squamous cell carcinoma.
P2860
Q24812299-939D2DDB-97B3-4828-B46A-D832CEDFC4BEQ28195858-0DA23E4D-74EC-4AB0-BC97-0F0A08EBBC92Q30826734-C3638272-1A00-4912-ADBF-61A71BCCA5A8Q33538899-55917EE4-93C3-4066-9DF9-2AD537EB6054Q33655825-6B20FAA9-4496-4973-B994-E54730CEA1D9Q34188015-3DAE1C16-1901-4FB4-A74A-768DD39413BBQ34619000-4927EB6F-DB77-4E70-815D-E8AEC599ABD2Q35046439-36425BD3-1E27-4675-ADEB-8EF25CD11A1FQ35059725-F9F7ADF2-E243-4676-9205-D6E501171BC9Q35139130-BE05EA38-6DE6-4C23-9BA1-367C6163C683Q35201592-19D0792E-71AD-4F70-B52A-D466E1C80029Q35604165-C1EDF9F0-952B-4EE9-B3CF-E68B79BEFB30Q35737724-6ADFFA5A-926D-45DD-8C53-EBBF82C31C27Q35799094-2B13ABD6-5D65-4C88-95B8-9FEB84FDD724Q35849115-A654666C-0AE0-43B1-BEA6-B828701129F1Q35998738-01E02729-A61B-49BC-A9E8-932616DAEB52Q36516722-5E5731B2-A961-48D8-AA25-D7B89FA35D92Q36577714-A3266441-D2D1-4B37-B5A5-E66A52448F16Q36787505-F1AAAA55-1D87-4A1C-8B47-F223C9A29044Q37180661-FD2C9388-0112-4D80-9768-CA8066891CC1Q37286671-FD26E595-F55F-4156-9226-D4DA2475C0F4Q39336275-99215B2E-09EF-4580-97D3-794E0A37F3CFQ39526451-EE6034DF-1CBB-42D8-85ED-C414938E8CD9Q39850984-6BD8723F-51FF-4E71-B808-7081DF9E7620Q40438247-9EF4E4FF-0384-4133-BDE3-4F053FB8E0FFQ41520738-01CAE46D-F9A4-4C84-AA34-F163089342F7Q46389749-3E867F10-4637-4BB7-AC17-95DE3C9957E5Q51141390-C73FFBA2-470A-49AB-B7AB-AD29FE515836Q53618954-97AEDCFF-9B4E-4F2B-8787-3EF0C2B6C0E7
P2860
Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Receptor binding cancer antige ...... of erythroid progenitor cells.
@ast
Receptor binding cancer antige ...... of erythroid progenitor cells.
@en
Receptor binding cancer antige ...... of erythroid progenitor cells.
@nl
type
label
Receptor binding cancer antige ...... of erythroid progenitor cells.
@ast
Receptor binding cancer antige ...... of erythroid progenitor cells.
@en
Receptor binding cancer antige ...... of erythroid progenitor cells.
@nl
prefLabel
Receptor binding cancer antige ...... of erythroid progenitor cells.
@ast
Receptor binding cancer antige ...... of erythroid progenitor cells.
@en
Receptor binding cancer antige ...... of erythroid progenitor cells.
@nl
P2093
P356
P1433
P1476
Receptor binding cancer antige ...... of erythroid progenitor cells.
@en
P2093
Matsushima T
Nakashima M
Nishimura J
Watanabe T
P304
P356
10.1182/BLOOD.V98.2.313
P407
P577
2001-07-01T00:00:00Z